IP Verse

Combination Therapies For Cancer

Patent No. EP3003316 (titled "Combination Therapies For Cancer") was filed by Glaxosmithkline on May 28, 2014. The application was issued on Jul 22, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PAJAROApr 21, 2021ALT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3003316

GLAXOSMITHKLINE
Application Number
EP14805105A
Filing Date
May 28, 2014
Status
Revoked
Jun 2, 2023
Publication Date
Jul 22, 2020
External Links
Slate, Register , Google Patents